SGEN Financial Facts
Net income (loss): -31.75MInvestment income, net: 660K
See Full Income Statement
Commitments and contingencies: 0
Deferred rent and other long-term liabilities: 2.81M
See Full Balance Sheet
Seattle Genetics Inc. (SGEN) Earnings
|
Expand Research on SGEN
| Next EPS Date | 4/24/24 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -17.8% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +3.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/16/19 |  |
Q219 | -$0.49 | -$0.38 | -$0.11 | $28.45M | $189.81M | = |  | | Details |
| 2/15/23 | Q422 | -$0.80 | -$1.03 | +$0.23 | $528.15M | $479.84M |  |
| | Details | |
7/26/16  |
|
Q216 | -$0.23 | -$0.32 | +$0.09 | $95.4M | $94.14M | N/A | | | Details |
| 4/30/20 | |
Q120 | -$0.98 | -$0.79 | -$0.19 | $198.51M | $207.14M | = | | | Details |
| 4/26/18 | |
Q118 | -$0.73 | N/A | N/A | $140.59M | $109.13M | = | | | Details |
| 7/31/14 |
|
Q214 | -$0.14 | -$0.23 | +$0.09 | $68.3M | $65.04M | N/A | | | Details |
| 7/29/21 | |
Q221 | -$0.47 | -$0.60 | +$0.13 | $388.47M | $355.03M | N/A | | | Details |
| 4/29/21 | |
Q121 | -$0.67 | -$0.61 | -$0.06 | $331.98M | $336.17M | N/A | | | Details |
